# The Ensign Group (ENSG)

Sector: Skilled nursing and senior living health care

| Field | Value |
|---|---|
| Price | $176.32 |
| Market cap | $10B |
| Intrinsic value source | AI estimate |
| Data as of | 2026-11-20 |
| Next earnings | 2027-01-27 (estimate) |

Analysts: Bullish

Picks: Research only

Discount category: Close to intrinsic value

## In short

The market weighs the fast earnings growth of Ensign against its dependence on Medicare and Medicaid rates, and higher occupancy at the operations it bought in 2025 and 2026 can lift its value.

## Themes and gap

- Themes: Regulation and courts (regulation-legal)
- Gap type: Can close (closable)
- Why: The Q4 2026 report, expected in late January 2027, and the CMS rate rule of mid-2027 show whether earnings keep growing near the 2026 rate.

## About

The Ensign Group, Inc. (ENSG) is based in San Juan Capistrano, California. Its independent subsidiaries operate skilled nursing and senior living facilities and give physical, occupational and speech therapy and other post-acute care services. At October 27, 2026, it had 418 healthcare operations in 18 states, and 34 of them also include senior living operations. Its real estate segment, Standard Bearer, owns 183 properties and leases them under triple-net leases, most of them to Ensign-affiliated operators. In 2025, revenue was $5.06 billion. Medicare and Medicaid gave 68.5% of revenue in Q3 2026. Ensign has nearly 60,000 employees, which it calls partners. The common stock trades on Nasdaq in US dollars. Ensign files 10-K and 10-Q reports.

## Thesis

The market prices The Ensign Group as a steady grower, because it raised its 2026 earnings guidance three times and its occupancy and skilled mix keep rising. The market also weighs the risk from government payers, because Medicare and Medicaid gave 68.5% of revenue in Q3 2026, and the One Big Beautiful Bill limits the provider taxes that many states use to fund Medicaid. For the AI estimate to rise, three things must be true. Ensign must reach its 2026 guidance of EPS of $7.94 to $8.02 and guide 2027 growth near its recent rate. The operations that it added in 2025 and 2026, including its first ones in Florida, must reach the occupancy and margins of its older operations. Medicaid rates in its main states, such as California, Texas and Arizona, must hold as the new provider tax rules start. The Q4 2026 report, expected in late January 2027, is the next test, and the CMS rule for Medicare rates in fiscal 2028, expected in mid-2027, shows the rate trend.

## Checkpoints

- Jan 27, 2027 (estimate): Q4 2026 results and 2027 guidance. Status: Pending. Watch: Ensign reaches its 2026 EPS guidance of $7.94 to $8.02 and guides 2027 EPS growth near 10% or more, and this passes; a lower result or weak 2027 guidance fails.
- Jul 2027 (estimate): CMS rule for Medicare rates in fiscal 2028. Status: Pending. Watch: The final CMS rule gives skilled nursing facilities a Medicare rate increase near past years, and this passes; a rate cut fails.
- 2027 (estimate): Medicaid rates under the new provider tax rules. Status: Pending. Watch: Medicaid rates in California, Texas and Arizona hold as the provider tax rules start, and this passes; rate cuts in these states fail.

## Valuation

The intrinsic value for The Ensign Group is an AI estimate from November 14, 2026. It is not an analyst's value. An AI research agent calculated it from the filings of The Ensign Group with the SEC. The method is a multiple of 2027 adjusted diluted earnings per share (EPS). The Q4 2025 release (8-K, February 4, 2026) gives 2025 revenue of $5.06 billion, GAAP diluted EPS of $5.84 and adjusted EPS of $6.57. The Q3 2026 release (8-K, October 27, 2026) gives Q3 revenue of $1,484.0 million, up 14.5%, GAAP diluted EPS of $1.76 and adjusted EPS of $2.03. It raises the 2026 guidance to EPS of $7.94 to $8.02 on about 59.5 million diluted shares, and to revenue of $5.89 billion to $5.92 billion. The guidance excludes share-based compensation, acquisition costs and other items. The Form 10-Q for the quarter ended September 30, 2026 gives cash and cash equivalents of $337.6 million, current investments of $54.1 million, $60.0 million drawn on the credit facility and mortgage loans of $141.2 million, so cash is larger than debt by about $190 million. It gives operating lease liabilities of $2,088.9 million. The estimate makes no adjustment for the net cash or the leases, because EPS already includes the interest income and the rent, which is an assumption. The cover of the 10-Q gives 58,340,666 shares at October 22, 2026, and the EPS of each case is per diluted share. The 2027 adjusted EPS and the multiples are assumptions. The low case assumes $8.55, about 7% growth, because states cut Medicaid rates after the federal limits on provider taxes and acquisitions slow, at 17 times. It gives $145.35 per share. The base case assumes $9.10, about 14% growth, from higher occupancy and skilled mix and the operations added in 2026, at 21 times. It gives $191.10 per share. The high case assumes $9.55, about 20% growth, near the rate of 2026, at 24 times. It gives $229.20 per share. The estimate assumes weights of 25%, 50% and 25%. The weighted intrinsic value is $189.19 per share. Ensign groups its operations in local clusters, and its Same Facilities had CMS quality ratings and survey results better than the industry in its states, which helps it to get referrals and to improve the facilities that it buys, but Medicare and Medicaid set most of its prices, and many operators compete for patients and staff.

As of 2026-11-14.

Sources:

- https://www.sec.gov/Archives/edgar/data/1125376/000112537626000047/q32026pressrelease.htm
- https://www.sec.gov/Archives/edgar/data/1125376/000112537626000046/ensg-20260930.htm
- https://www.sec.gov/Archives/edgar/data/1125376/000112537626000008/q42025pressrelease.htm

## Balance sheet

- Cash: $392M
- Debt: $201M
- Net cash: $191M
- Undrawn credit line: $732M, to August 2031
- Debt due within 12 months: $4.0M

At September 30, 2026, Ensign had cash and cash equivalents of $337.6 million and current investments of $54.1 million. Debt was $60.0 million drawn on the revolving credit facility and $141.2 million of mortgage loans insured with HUD, at fixed rates and with terms of 25 to 35 years. The credit facility of $800 million runs to August 19, 2031, and $731.6 million was available. Operating lease liabilities were $2,088.9 million, and future lease payments were $3.1 billion. Accrued self-insurance liabilities were $312.7 million. Total equity was $2,563.4 million.

As of 2026-09-30.

Sources:

- https://www.sec.gov/Archives/edgar/data/1125376/000112537626000046/ensg-20260930.htm
- https://www.sec.gov/Archives/edgar/data/1125376/000112537626000047/q32026pressrelease.htm
- https://www.sec.gov/Archives/edgar/data/1125376/000112537626000038/pressrelease-revolver.htm

## Dividends

- Dividend yield: 0.1% (last 12 months, at the current price)
- Paid per share, last 12 months: $0.26 (4 payments)
- Current annual rate: $0.26 ($0.065 x 4 a year)
- Payout ratio: 4% of the earnings of the last fiscal year (the year ended 2025-12-31)
- Latest ex-dividend date: 2026-09-30, $0.065 per share
- Growth from 2020 to 2025: 4.6% a year
- Growth from 2016 to 2025: 5.8% a year

Dividends per share by year: 2016: $0.1525, 2017: $0.1628, 2018: $0.1712, 2019: $0.1847, 2020: $0.203, 2021: $0.214, 2022: $0.223, 2023: $0.234, 2024: $0.243, 2025: $0.254.

Source: company filings and market data, read on 2026-11-13.

## Recent events

- 2026-10-27: Ensign reported Q3 2026 results. Revenue rose 14.5% to $1.48 billion, GAAP diluted EPS rose 23.9% to $1.76 and adjusted EPS rose 23.8% to $2.03. Same Facilities occupancy was 84.1%. Ensign raised its 2026 EPS guidance to $7.94 to $8.02 and the low end of its revenue guidance to $5.89 billion.
- 2026-10-27: Ensign said that it added 22 new operations during and after Q3 2026, including its first operations in Florida. It bought the real estate of five facilities that it operated under leases. Its portfolio now has 418 healthcare operations in 18 states.
- 2026-08-20: Ensign increased its revolving credit facility to $800 million and extended its maturity to August 19, 2031.
- 2026-07-27: Ensign reported Q2 2026 results. Revenue rose 17.3% to $1.44 billion, GAAP diluted EPS was $1.68 and adjusted EPS rose 20.8% to $1.92. Ensign raised its 2026 EPS guidance to $7.75 to $7.85 and its revenue guidance to $5.87 billion to $5.92 billion.
- 2026-06-15: The Board added $60 million to the stock repurchase program of May 13, 2026, for a total of $100 million.
- 2026-04-30: Ensign reported Q1 2026 results. Revenue rose 18.4% to $1.39 billion, GAAP diluted EPS was $1.67 and adjusted EPS rose 21.7% to $1.85. Ensign raised its 2026 EPS guidance to $7.48 to $7.62.
- 2026-02-04: Ensign reported 2025 results. Revenue rose 18.7% to $5.06 billion, GAAP diluted EPS was $5.84 and adjusted EPS was $6.57. It gave 2026 guidance of EPS of $7.41 to $7.61 and revenue of $5.77 billion to $5.84 billion.

## Latest news and filings

- Last earnings: 2026-10-27 (8-K: https://www.sec.gov/Archives/edgar/data/1125376/000112537626000047/)
- Next earnings: 2027-01-27 (expected; the company has not confirmed it)

| Filed | Form | Headline | Period end | XBRL document | Link |
| --- | --- | --- | --- | --- | --- |
| 2026-10-27 | 8-K | Earnings release |  | ensg-20261027 | https://www.sec.gov/Archives/edgar/data/1125376/000112537626000047/ |
| 2026-10-27 | 10-Q | Quarterly report for the period ended Sep 30, 2026 | 2026-09-30 | ensg-20260930 | https://www.sec.gov/Archives/edgar/data/1125376/000112537626000046/ensg-20260930.htm |
| 2026-08-25 | 8-K | Change to shareholder rights or bylaws |  | ensg-20260820 | https://www.sec.gov/Archives/edgar/data/1125376/000112537626000040/ensg-20260820.htm |
| 2026-08-20 | 8-K | New material agreement and New debt or financial obligation |  | ensg-20260819 | https://www.sec.gov/Archives/edgar/data/1125376/000112537626000038/ensg-20260819.htm |
| 2026-07-27 | 8-K | Earnings release |  | ensg-20260727 | https://www.sec.gov/Archives/edgar/data/1125376/000112537626000036/ |
| 2026-07-27 | 10-Q | Quarterly report for the period ended Jun 30, 2026 | 2026-06-30 | ensg-20260630 | https://www.sec.gov/Archives/edgar/data/1125376/000112537626000034/ensg-20260630.htm |
| 2026-06-15 | 8-K | Other company news |  | ensg-20260612 | https://www.sec.gov/Archives/edgar/data/1125376/000112537626000031/ensg-20260612.htm |
| 2026-06-10 | 8-K | Other company news |  | ensg-20260513 | https://www.sec.gov/Archives/edgar/data/1125376/000112537626000029/ensg-20260513.htm |
| 2026-05-18 | 8-K | Shareholder vote results |  | ensg-20260513 | https://www.sec.gov/Archives/edgar/data/1125376/000112537626000026/ensg-20260513.htm |
| 2026-04-30 | 8-K | Earnings release |  | ensg-20260430 | https://www.sec.gov/Archives/edgar/data/1125376/000112537626000023/ |

Every filing on SEC EDGAR (CIK 1125376): https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001125376&type=&dateb=&owner=include&count=40

## Risks

- Medium: Medicare and Medicaid gave 68.5% of revenue in Q3 2026. The One Big Beautiful Bill and a CMS rule of 2026 limit the provider taxes that states use to fund Medicaid, so states such as California, Colorado and Nevada can pay lower rates.
- Medium: Ensign grows mainly by buying and turning around facilities, and it added 122 new operations since 2024. New operations can take longer to reach good occupancy and margins, and good acquisitions can become harder to find.
- Medium: Ensign had $3.1 billion of future operating lease payments at September 30, 2026. Rent is a fixed cost, so lower occupancy or lower rates reduce margins fast.
- Low: Ensign insures part of its general and professional liability through its own captive insurance subsidiary. Its accrued self-insurance liabilities were $312.7 million at September 30, 2026, and large claims can increase costs.
- Low: The current administration stopped the federal minimum staffing rule for nursing homes, but a later administration or Congress can bring back staffing rules that increase labor costs.

## Links

- Page: https://picks.utilarium.app/company/ENSG/
- History of changes: https://picks.utilarium.app/company/ENSG/history/
- JSON with full history: https://picks.utilarium.app/data/company/ENSG.json

> Picks is a personal record of stock picks. It gives general opinions about stocks, including a "Top pick" label. They are not tailored to your needs, goals or risk tolerance. Kevin is not a registered adviser and relies on the general-advice exemption in Canadian securities law (NI 31-103 s.8.25). Do your own research, or ask a registered adviser. Kevin may hold any stock on this site. Prices, intrinsic values and ratings can be delayed or wrong; check the original source. Full disclaimer: /disclaimer/.
